Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Desert Gold Report Results from 3,900 Meter Phase 2 Exploration Drill Program (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Avanos Medical Inc AVNS

Healthcare Medical Instruments & Supplies
Avanos Medical, Inc. is a medical device company, which is focused on delivering solutions. The Company offers healthcare needs, such as providing nutrition to patients from hospital to home and reducing the use of opioids while helping patients move from surgery to recovery. The Company conducts its business in one segment that provides its medical device products to healthcare providers and... see more

Recent & Breaking News (NYSE:AVNS)

Avanos Medical, Inc. to Present at the Virtual KeyBanc 2022 Life Sciences & MedTech Investor Forum

PR Newswire March 15, 2022

Avanos Medical, Inc. Announces Fourth Quarter and Full-Year 2021 Results

PR Newswire February 23, 2022

Avanos Medical, Inc. to Webcast Conference Call Discussing Fourth Quarter and Full Year 2021 Financial Results

PR Newswire February 15, 2022

Avanos Medical, Inc. to Present at the 40th Annual J.P. Morgan Healthcare Conference

PR Newswire January 10, 2022

Avanos Medical, Inc. Announces Share Repurchase Authorization

PR Newswire December 15, 2021

Avanos Medical, Inc. Announces Agreement To Acquire OrthogenRx, Inc.

PR Newswire December 13, 2021

Avanos Medical, Inc. Launches PainBlock Pro App

PR Newswire December 2, 2021

Avanos Medical, Inc. Announces Third Quarter 2021 Results

PR Newswire November 2, 2021

Avanos Medical, Inc. To Webcast Conference Call Discussing Third Quarter 2021 Financial Results

PR Newswire October 26, 2021

Avanos Medical, Inc. Announces Second Quarter 2021 Results

PR Newswire August 3, 2021

Avanos Medical, Inc. To Webcast Conference Call Discussing Second Quarter 2021 Financial Results

PR Newswire July 27, 2021

Avanos Medical, Inc. Appoints Moji James as Senior Vice President & General Counsel

PR Newswire July 12, 2021

Avanos Medical, Inc. to Present at the 2021 Raymond James Human Health Innovation Conference

PR Newswire June 18, 2021

Charles River Laboratories International Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600

PR Newswire May 10, 2021

Avanos Medical, Inc. Announces First Quarter 2021 Results

PR Newswire May 7, 2021

Avanos Medical, Inc. To Webcast Conference Call Discussing First Quarter 2021 Financial Results

PR Newswire April 30, 2021

Avanos Medical, Inc. to Present at the KeyBanc Life Sciences & MedTech Investor Forum

PR Newswire March 16, 2021

Avanos Medical, Inc. to Present at the Virtual Raymond James 42nd Annual Institutional Investors Conference

PR Newswire February 24, 2021

Avanos Medical, Inc. Announces Fourth Quarter and Full-Year 2020 Results

PR Newswire February 18, 2021

Avanos Medical, Inc. to Webcast Conference Call Discussing Fourth Quarter and Full-Year 2020 Financial Results

PR Newswire February 11, 2021